Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. - Zamulko O; Karivedu V; Riaz MK; Monroe I; Romano A; Mulanda R; Kurtzweil N; Forsythe A; Allen CL; Harun N; Pan J; Rai S; et al. (Cancer research communications, 2025)